Stewart Tepper
Stewart Tepper
Professor of Neurology, Geisel School of Medicine at Dartmouth
Verified email at Dartmouth.edu
TitleCited byYear
A six-item short-form survey for measuring headache impact: The HIT-6™
M Kosinski, MS Bayliss, JB Bjorner, JE Ware, WH Garber, A Batenhorst, ...
Quality of Life Research 12 (8), 963-974, 2003
5952003
Efficacy of gabapentin in migraine prophylaxis
NT Mathew, A Rapoport, J Saper, L Magnus, J Klapper, N Ramadan, ...
Headache: The Journal of Head and Face Pain 41 (2), 119-128, 2001
3982001
Transformed migraine and medication overuse in a tertiary headache centre–clinical characteristics and treatment outcomes
ME Bigal, AM Rapoport, FD Sheftell, SJ Tepper, RB Lipton
Cephalalgia 24 (6), 483-490, 2004
2532004
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study
SJ Tepper, CGH Dahlöf, A Dowson, L Newman, H Mansbach, M Jones, ...
Headache: The Journal of Head and Face Pain 44 (9), 856-864, 2004
2172004
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine
ME Bigal, AM Rapoport, RB Lipton, SJ Tepper, FD Sheftell
Headache: The Journal of Head and Face Pain 43 (4), 336-342, 2003
2052003
Chronic daily headache: identification of factors associated with induction and transformation
ME Bigal, FD Sheftell, AM Rapoport, SJ Tepper, RB Lipton
Headache: The Journal of Head and Face Pain 42 (7), 575-581, 2002
1742002
Applications of computerized adaptive testing (CAT) to the assessment of headache impact
JE Ware Jr, M Kosinski, JB Bjorner, MS Bayliss, A Batenhorst, ...
Quality of Life Research 12 (8), 935-952, 2003
1712003
Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study
ME Bigal, CA Bordini, SJ Tepper, JG Speciali
Cephalalgia 22 (5), 345-353, 2002
1702002
Mechanisms of action of the 5-HT1B/1D receptor agonists
SJ Tepper, AM Rapoport, FD Sheftell
Archives of neurology 59 (7), 1084-1088, 2002
1662002
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine
CN Sang, NM Ramadan, RG Wallihan, AS Chappell, FG Freitag, ...
Cephalalgia 24 (7), 596-602, 2004
1512004
Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches
M Ansarinia, A Rezai, SJ Tepper, CP Steiner, J Stump, M Stanton‐Hicks, ...
Headache: The Journal of Head and Face Pain 50 (7), 1164-1174, 2010
1302010
Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic …
ME Bigal, FD Sheftell, AM Rapoport, RB Lipton, SJ Tepper
Cephalalgia 22 (6), 432-438, 2002
1222002
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
S Tepper, M Ashina, U Reuter, JL Brandes, D Doležil, S Silberstein, ...
The Lancet Neurology 16 (6), 425-434, 2017
1182017
The effect of weather on headache
PB Prince, AM Rapoport, FD Sheftell, SJ Tepper, ME Bigal
Headache: The Journal of Head and Face Pain 44 (6), 596-602, 2004
1162004
Drug-induced serotonin syndrome: a review
C Sun-Edelstein, SJ Tepper, RE Shapiro
Expert opinion on drug safety 7 (5), 587-596, 2008
1122008
Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation
SJ Tepper, A Rezai, S Narouze, C Steiner, P Mohajer, M Ansarinia
Headache: The Journal of Head and Face Pain 49 (7), 983-989, 2009
1102009
Primary chronic daily headache and its subtypes in adolescents and adults
ME Bigal, RB Lipton, SJ Tepper, AM Rapoport, FD Sheftell
Neurology 63 (5), 843-847, 2004
1092004
Medications Associated with Probable Medication Overuse Headache Reported in a Tertiary Care Headache Center Over a 15‐Year Period: CME
CA Meskunas, SJ Tepper, AM Rapoport, FD Sheftell, ME Bigal
Headache: The Journal of Head and Face Pain 46 (5), 766-772, 2006
1062006
Peripheral nerve blocks and trigger point injections in headache management–a systematic review and suggestions for future research
A Ashkenazi, A Blumenfeld, U Napchan, S Narouze, B Grosberg, R Nett, ...
Headache: The Journal of Head and Face Pain 50 (6), 943-952, 2010
992010
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin‐norepinephrine reuptake inhibitors …
RW Evans, SJ Tepper, RE Shapiro, C Sun‐Edelstein, GE Tietjen
Headache: The Journal of Head and Face Pain 50 (6), 1089-1099, 2010
892010
The system can't perform the operation now. Try again later.
Articles 1–20